News & Press Releases

CELLERANT AWARDED SBIR CONTRACT FUNDING TO DEVELOP CLT-009 FOR TREATMENT OF THROMBOCYTOPENIA
October 8, 2012

CELLERANT AWARDED $36.4 MILLION OPTION UNDER EXISTING U.S. GOVERNMENT CONTRACT TO SUPPORT DEVELOPMENT OF CLT-008 FOR TREATMENT OF ACUTE RADIATION SYNDROME
September 4, 2012

CELLERANT TO PRESENT AT THE INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH (ISSCR) 10TH ANNUAL MEETING IN JAPAN
June 15, 2012

CELLERANT APPOINTS GISELA SCHWAB, M.D., TO ITS BOARD OF DIRECTORS AND NAMES LOWELL SEARS AS CHAIRMAN OF THE BOARD
June 14, 2012

CELLERANT ANNOUNCES PUBLICATION DEMONSTRATING SIGNIFICANT SURVIVAL BENEFITS AND PRECLINICAL PROOF OF CONCEPT WITH MYELOID PROGENITORS AS RADIATION COUNTERMEASURE
May 14, 2012

CELLERANT THERAPEUTICS APPOINTS LOWELL E. SEARS TO BOARD OF DIRECTORS
February 21, 2012

 

Copyright ©2006-2016 Cellerant Therapeutics, Inc.